All News

Osilodrostat Effective for Cushing’s Disease

Tags: Conference Dispatch

KOL Views Results: VARSITY may boost community use of Entyvio and pressure insurers partial to Humira, says IBD expert

Ref: KOL Views Desk

Tags: KOL Views Results Takeda J&J AbbVie Roche Irritable Bowel Syndrome FDA Marketing & Sales Medical Affairs Entyvio Humira Remicade etrolizumab

ViewPoints: Hurdles cleared but question remains for Aimmune’s AR101

Ref: ViewPoints Desk

Tags: ViewPoints Aimmune Therapeutics DBV Allergies FDA Clinical Research (R&D) Marketing & Sales Medical Affairs AR101 Viaskin Peanut

Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results

Ref: GlobeNewswire

Tags: Press Release Aeterna Zentaris Corporate Affairs

Adial Pharmaceuticals Announces Appointment of Bankole Johnson, M.D., as Chief Medical Officer

Ref: Accesswire

Tags: People News ADial Pharmaceuticals Corporate Affairs

Natera to Partner with AMAL Therapeutics on Clinical Trial Using Signatera MRD Test to Assess Treatment Response to Colorectal Cancer Vaccine

Ref: PR Newswire

Tags: Press Release Amal Therapeutics Colorectal Cancer Immunisation Corporate Affairs ATP128

Lilly and ImmuNext Announce Licensing and Research Collaboration

Ref: Eli Lilly

Tags: Press Release Lilly ImmuNext Corporate Affairs Licensing

Memorandum of Understanding for Confirmatory Trial to Support Marketing Approval of Revascor for Reduction of Gastrointestinal Bleeding in LVAD Patients

Ref: GlobeNewswire

Tags: Press Release Mesoblast Clinical Research (R&D)Revascor

Revcovi, Japan’s First Drug for ADA Deficiency, Receives Marketing Approval

Ref: Teijin Pharma

Tags: Press Release Teijin Leadiant Biosciences MHLW Marketing & Sales Regulatory Affairs Revcovi

ProQR spins out all Dystrophic Epidermolysis Bullosa activities into newly formed Wings Therapeutics created by EB Research Partnership

Ref: GlobeNewswire

Tags: Press Release ProQR Therapeutics Wings Therapeutics Corporate Affairs QR-313